跳至主要内容
临床试验/NCT02538302
NCT02538302已完成3 期

Minirin Versus Oxybutynin for Nocturnal Enuresis in Children

Hormozgan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2013年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
66
试验地点
1
主要终点
ّFrequency of nocturnal enuresis

研究概览

简要总结

Nocturnal enuresis is among the most common disorders in children. The aim of current study was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal enuresis in children in Bandar Abbas in 2014.

详细描述

Nocturnal enuresis is among the most common disorders in children. Several pharmacological and non-pharmacological treatments are available for nocturnal enuresis. Studies for reaching the best pharmacological treatment for this disorder are continuing. The aim of current study was to compare the efficacy and safety of Minirin and oxybutynin for treatment of nocturnal enuresis in children in Bandar Abbas in 2014.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
5 Years 至 14 Years(Child)
性别
All
接受健康志愿者

入选标准

  • >5 years old
  • Nocturnal enuresis
  • Candidate for pharmacological treatment

排除标准

  • Children who their parents did noted filled the informed consent form
  • Impossibility of follow up during the study period
  • History of seizure
  • History of rheumatologic disorders such as sjogren's disease

研究组 & 干预措施

Minirin

Experimental

120 microgram per day for 2 months, then 60 microgram per day for 2 months, then 60 microgram every two days for two months

干预措施: Minirin (Drug)

Oxybutynin

Active Comparator

5 mg Oxybutynin twice a daily for 6 months

干预措施: Oxybutynin (Drug)

结局指标

主要结局

ّFrequency of nocturnal enuresis

时间窗: 6 months

Number of participants with nocturnal enuresis

次要结局

  • Frequency of urinary incontinency(6 months)
  • Frequency of urgency(6 months)
  • Frequency of Xerostomia(6 months)
  • Frequency of Xerophthalmia(6 months)
  • Frequency of Blurred vision(6 months)
  • Frequency of Dysphagia(6 months)
  • Frequency of constipation(6 months)
  • Frequency of Diarrhea(6 months)
  • Frequency of Headache(6 months)
  • Frequency of Seizure(6 months)
  • Frequency of Epistaxis(6 months)
  • Frequency of Abdominal pain(6 months)
  • Frequency of Vomiting(6 months)
  • Frequency of Ear ache(6 months)
  • Frequency of Rhinitis(6 months)
  • Frequency of Chest pain(6 months)
  • Frequency of Increase in appetite(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hamidreza Mahboobi

Principal Investigator

Hormozgan University of Medical Sciences

研究点 (1)

Loading locations...

相似试验